Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neurobo Pharmaceuticals Inc.

Clinical trials sponsored by Neurobo Pharmaceuticals Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Obesity drug DA-1726 tested in humans for first time Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Obesity drug DA-1726 tested in humans for first time

Disease control Recruiting now

This early-stage trial tests a new drug called DA-1726 in 139 people with obesity. The main goal is to check safety and side effects. Researchers will also measure how the drug moves through the body and its effect on weight. Participants receive either the drug or a placebo, and…

Phase 1 • Sponsor: NeuroBo Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC